Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)

Gilead Sciences (GILD) has 8 years of Current Deferred Tax Assets data on file, last reported at $857.0 million in Q4 2016.

• For the quarter ending Q4 2016, Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million; the trailing twelve-month figure through Dec 2016 stood at $857.0 million (up 3.5% YoY), and the FY2016 full-year result was $857.0 million, up 3.5% from the prior year.
• Current Deferred Tax Assets for Q4 2016 stood at $857.0 million, up from $762.0 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $894.0 million in Q3 2015 and bottomed at $193.9 million in Q1 2012.
• The 5-year median for Current Deferred Tax Assets is $385.6 million (2014), against an average of $501.1 million.
• The widest annual swing landed in 2012, when Current Deferred Tax Assets plunged 30.2%; it then jumped 132.46% in 2015.
• A 5-year view of Current Deferred Tax Assets shows it stood at $262.6 million in 2012, then advanced by 26.03% to $331.0 million in 2013, then surged by 53.47% to $508.0 million in 2014, then jumped by 62.99% to $828.0 million in 2015, then increased by 3.5% to $857.0 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $857.0 million (Q4 2016), $762.0 million (Q3 2016), and $835.0 million (Q2 2016), per Business Quant data.

Peer Comparison